Cargando…
Vitamin C and COVID-19: should clinical trials be prioritised for low income settings and vitamin C-deficient populations?
Autores principales: | Carr, Anitra C., Rowe, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692501/ https://www.ncbi.nlm.nih.gov/pubmed/38046392 http://dx.doi.org/10.51893/2021.1.L1 |
Ejemplares similares
-
Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern?
por: Rowe, Sam, et al.
Publicado: (2020) -
Factors Affecting Vitamin C Status and Prevalence of Deficiency: A Global Health Perspective
por: Carr, Anitra C., et al.
Publicado: (2020) -
Is the VITAMINS RCT indicating potential redundancy between corticosteroids and vitamin C?
por: Carr, Anitra C.
Publicado: (2020) -
The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19
por: Carr, Anitra C., et al.
Publicado: (2020) -
A new clinical trial to test high-dose vitamin C in patients with COVID-19
por: Carr, Anitra C.
Publicado: (2020)